ADB Sells $ 3 Billion Global 3-Year Benchmark Bonds – India Education | Latest Education News | Global education news

MANILA – The Asian Development Bank (ADB) re-entered the US dollar bond market with the price of a 3-year $ 3 billion global bond, the proceeds of which will form part of the ADB’s ordinary capital resources.

“This 3-year transaction closes a phenomenal year for ADB in capital markets,” said AfDB Treasurer Pierre Van Peteghem. “Given the strong order book of over $ 6.6 billion, the final price was set at 2 basis points as part of the initial pricing thoughts with a print size of $ 3 billion that was in line with our remaining global US dollar market funding requirements for 2021. ”

“Investor interest in our good work was as impressive as ever, especially amid lingering concerns about the COVID-19 pandemic. We thank the AfDB’s global investors for their continued support to our mission and the financial assistance provided to our members in these troubled times, ”added Mr. Van Peteghem.

The 3-year bond, with a coupon of 0.625% per annum payable semi-annually and a maturity date of October 8, 2024, was valued at 99.946% for a yield of 9.1 basis points against US Treasuries at 0.375% maturing in September 2024.

The transaction was led by BofA Securities, Morgan Stanley, Nomura and RBC Capital Markets. A syndicate group was also formed, made up of BNP Paribas, CIBC Capital Markets, Scotiabank and SEB.

The issue was widely distributed on the primary market with 20% of the bonds placed in Asia; 44% in Europe, the Middle East and Africa; and 36% in the Americas. By type of investor, 65% of bonds went to central banks and official institutions, 24% to banks and 11% to fund managers and other types of investors.

The AfDB plans to raise around $ 34 billion to $ 36 billion in capital markets in 2021.

The AfDB is committed to achieving a prosperous, inclusive, resilient and sustainable Asia and the Pacific, while continuing its efforts to eradicate extreme poverty. Founded in 1966, it is owned by 68 members, including 49 from the region.

About William G.

Check Also

The Primary Sclerosing Cholangitis market is expected to experience tremendous growth in the coming years with the profiling of prominent companies like Acorda Therapeutics, Gilead Sciences, NGM Biopharmaceuticals

Primary sclerosing cholangitis (PSC) is a disease of the liver that causes inflammation of the …